Argos Therapeutics' Series C - II Round

Argos Therapeutics raised a round of funding on November 21, 2008.

Argos Therapeutics, formerly Merix Bioscience, s a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infe…

Articles about Argos Therapeutics' Series C - II Round: